Non-Alcoholic Steatohepatitis Treatment Market Analysis 2022-2030: Focus on Cenicriviroc, Elafibranor, Ocaliva (Obeticholic Acid), Selonsertib – ResearchAndMarkets.com

Non-Alcoholic Steatohepatitis Treatment Market Analysis 2022-2030: Focus on Cenicriviroc, Elafibranor, Ocaliva (Obeticholic Acid), Selonsertib – ResearchAndMarkets.com




Non-Alcoholic Steatohepatitis Treatment Market Analysis 2022-2030: Focus on Cenicriviroc, Elafibranor, Ocaliva (Obeticholic Acid), Selonsertib – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Non-Alcoholic Steatohepatitis Treatment Market, by Drug, by Distribution Channel, and by Region – Size, Share, Outlook, and Opportunity Analysis, 2022 – 2030” report has been added to ResearchAndMarkets.com’s offering.

This report provides an in-depth analysis of the global nonalcoholic steatohepatitis treatment market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2022-2030), considering 2021 as the base year

By 2050, this is projected at >29 million people – a 165% increase over the 2000 level. It is to be noted that these projections imply a steady increase in the overall prevalence of diabetes, from 3.99% in 2000 to 7.21% in 2050.

However, diagnosis of the nonalcoholic steatohepatitis can be difficult to capture in an early stage and can take years before patients show any sort of symptoms which is a major factor hampering the nonalcoholic steatohepatitis treatment market.

Key features of the study:

  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global nonalcoholic steatohepatitis treatment market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global nonalcoholic steatohepatitis treatment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global nonalcoholic steatohepatitis treatment market

Company Profiles:

  • AstraZeneca Plc.
  • Company Highlights
  • Products Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
  • Conatus Pharmaceuticals
  • Enzo Biochem, Inc.
  • GENFIT SA
  • Galmed Pharmaceuticals Ltd.
  • Gilead Science
  • Immuron Ltd.
  • Intercepts Pharmaceuticals
  • Novo Nordisk
  • Raptor Pharmaceutical Corporation
  • Tobira Therapeutics, Inc.

Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

Market Purview

  • Report Description
  • Market Definition and Scope
  • Executive Summary
  • Market Snapshot, By Drug
  • Market Snapshot, By Distribution Channel
  • Market Snapshot, By Region
  • Publisher Opportunity Map

Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
  • Drivers
  • Restraints
  • Market Opportunities
  • Impact Analysis
  • Market Trends
  • Recent Developments
  • Acquisitions and Partnerships Scenario
  • Technology Overview
  • Regulatory Scenario
  • Pricing Analysis
  • PEST Analysis
  • Pipeline Product Analysis
  • Epidemiology Study

Global Nonalcoholic Steatohepatitis Treatment Market- Impact of Coronavirus (Covid-19) Pandemic

  • Overall Impact
  • Government Initiatives
  • COVID-19 Impact on the market

Detailed Segmentation:

Global Nonalcoholic Steatohepatitis Treatment Market, By Drug:

  • Cenicriviroc
  • Elafibranor
  • Ocaliva (Obeticholic Acid)
  • Selonsertib

Global Nonalcoholic Steatohepatitis Treatment Market, By Distribution Channel:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

Global Nonalcoholic Steatohepatitis Treatment Market, By Region:

  • North America
  • U.S.
  • Canada
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Europe
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
  • South Africa
  • Central Africa
  • North Africa

For more information about this report visit https://www.researchandmarkets.com/r/t0uc4y

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T. Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900